Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2009
10/22/2009US20090263865 Substance Specific to Human PD-1
10/22/2009US20090263864 Recombinant production of mixtures of antibodies
10/22/2009US20090263863 Modification of protein glycosylation in methylotrophic yeast
10/22/2009US20090263861 HOST-VECTOR SYSTEM ANTIBIOTIC-FREE ColE1 PLASMID PROPAGATION
10/22/2009US20090263860 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cell proliferative disorders
10/22/2009US20090263859 Thermophilic and thermoacidophilic glycosylation genes and enzymes from Alicyclobacillus acidocaldarius and related organisms, methods
10/22/2009US20090263847 Lsr receptor, its activity, its cloning and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
10/22/2009US20090263846 Oxygen-resistant hydrogenases and methods for designing and making same
10/22/2009US20090263808 Genetic Analysis For Stratification of Cancer Risk
10/22/2009US20090263796 Methods and compositions for diagnosing or monitoring autoimmune and chronic inflammatory diseases
10/22/2009US20090263789 Method for Detecting Nucleic Acid Sequences
10/22/2009US20090263788 Efficient algorithm for pcr testing of blood samples
10/22/2009US20090263783 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses
10/22/2009US20090263554 Nucleic acid molecules encoding enzymes from wheat which are involved in starch synthesis
10/22/2009US20090263452 Drug-eluting intravascular prostheses and methods of use
10/22/2009US20090263425 Methods of stimulating an immune response against prostate specific antigen
10/22/2009US20090263420 Virus-Like Particles As Vaccines For Paramyxovirus
10/22/2009US20090263418 Means and methods for manipulating sequential phagolysomalcytosolic translocation of mycobacteria, and uses thereof
10/22/2009US20090263412 Non-Splicing Variants of gp350/220
10/22/2009US20090263411 Compositions, splice variants and methods relating to ovarian specific genes and proteins
10/22/2009US20090263410 Use of tgf-b1 inhibitor peptides in the preparation of an immune response modulating agent
10/22/2009US20090263405 CpG OLIGONUCLEOTIDE PRODRUGS, COMPOSITIONS THEREOF AND ASSOCIATED THERAPEUTIC METHODS
10/22/2009US20090263404 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor
10/22/2009US20090263403 DNAX Accessory Protein, 12 kD (DAP12); useful in modulating development of cells such as lymphoid and myeloid; for modulating of immune responses; fusion proteins
10/22/2009US20090263395 Genes and polypeptides relating to breast cancers
10/22/2009US20090263394 A34 and a33-like 3 dna protein, antibodies thereto and methods of treatment using same
10/22/2009US20090263383 Antibodies to angiogenesis inhibiting domains of CD148
10/22/2009US20090263382 Stable and soluble antibodies inhibiting tnf alpha
10/22/2009US20090263379 Monoclonal antibodies for inhibition of laminin-8 expression to inhibit human gliomas
10/22/2009US20090263364 Method and constructs for delivering double stranded rna to pest organisms
10/22/2009US20090263354 Compositions and siRNAs for inhibiting C/EBPbeta
10/22/2009US20090263323 Novel means and methods for the treatment of hearing loss and phantom hearing
10/22/2009US20090263280 Systems for using sample processing devices
10/22/2009CA2726396A1 Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid
10/22/2009CA2725427A1 Genetics variants associated with hiv disease restriction
10/22/2009CA2721673A1 Method of separating and purifying cellular components using non-covalent bond between cucurbituril derivative and guest compound and apparatus using the same
10/22/2009CA2721653A1 Expression vector
10/22/2009CA2721380A1 Silencing of csn5 gene expression using interfering rna
10/22/2009CA2721333A1 Novel lipid formulations for nucleic acid delivery
10/22/2009CA2721332A1 Plants having enhanced yield-related traits and a method for making the same
10/22/2009CA2721231A1 Sequence diversity generation in immunoglobulins
10/22/2009CA2721108A1 Polypeptides having ferulic acid esterase activity and polynucleotides encoding same
10/22/2009CA2720675A1 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
10/22/2009CA2720652A1 Functional enhancement of yeast to minimize production of ethyl carbamate via modified transporter expression
10/21/2009EP2110669A1 Methods for the identification of allo-antigens and their use for cancer therapy and transplantation
10/21/2009EP2110666A1 New method of detecting and analysing protein interactions in vivo
10/21/2009EP2110445A2 Molecular tagging system
10/21/2009EP2110442A1 Methods for disease detection
10/21/2009EP2110440A2 Regulated vectors for controlling DNA hypermutability in eukaryotic cells
10/21/2009EP2110437A1 Methods for increasing the resistance of plants to hypoxic conditions
10/21/2009EP2110436A1 Polypeptides having neutrophil stimulating activity
10/21/2009EP2110435A1 Method for the preparation of a nucleic acid library
10/21/2009EP2110434A1 Type-1 cytokine receptor GLM-R
10/21/2009EP2110432A2 High fidelity DNA polymerase compositions and uses therefor
10/21/2009EP2110385A1 Stabilized factor VIII with engineered disulfide bonds
10/21/2009EP2110384A1 Hepatopoietin and use thereof
10/21/2009EP2110382A1 Infectious cDNA of an improved vaccine strain of measles virus, use for immunogenic compositions
10/21/2009EP2110379A2 Mammalian sphingosine kinase type 2 isoforms, and uses thereof
10/21/2009EP2109680A2 Novel gene disruptions, compositions and methods relating thereto
10/21/2009EP2109679A1 Pearli1 - like pathogen control genes and methods of use in plants
10/21/2009EP2109678A1 Nematode inducible plant mtn3-like gene promotors and regulatory elements
10/21/2009EP2109677A1 Plants having enhanced yield-related traits and a method for making the same
10/21/2009EP2109676A1 Modified ppase expression in sugar beet
10/21/2009EP2109675A1 Method for preparing butanol through butyryl-coa as an intermediate using yeast
10/21/2009EP2109674A2 High expression cell line that eliminates gene amplification
10/21/2009EP2109672A1 Dna sequence encoding penicillin acylase, novel recombinant dna constructs and recombinant microorganisms carrying this sequence
10/21/2009EP2109671A2 Expression cassette, use of the expression cassette, vector, host cell, a method for producing a polypeptide
10/21/2009EP2109670A1 Production of a lipid acyltransferase from transformed bacillus licheniformis cells
10/21/2009EP2109361A1 A transgenic animal and a method of producing it
10/21/2009EP2109356A2 Polypeptides having phytase activty and polynucleotides encoding same
10/21/2009EP1807697B1 Double hybrid system based on gene silencing by transcriptional interference
10/21/2009EP1781802B1 Production of a tnfr-ig fusion protein
10/21/2009EP1666586B1 Pyrroloquinoline quinone (pqq)-dependent glucose dehydrogenase modification having excellent substrate specificity
10/21/2009EP1590467B1 Use of regulatory sequences for specific, transient expression in neuronal determined cells
10/21/2009EP1516050B1 Generation of plants with improved pathogen resistance
10/21/2009EP1501465B1 Vectors having both isoforms of beta-hexosaminidase
10/21/2009EP1499885B1 Novel fusion proteins and assays for molecular binding
10/21/2009EP1496118B1 Method of measuring human cyp3a inducibility
10/21/2009EP1429623B1 Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses
10/21/2009EP1423413B1 Peptidic compounds selectively binding to p-selectin
10/21/2009EP1415154B1 Control of growth and repair of gastro-intestinal tissues by gastrokines
10/21/2009EP1409669B1 Root specific, stimulant inducible promoter and its use
10/21/2009EP1408736B1 Plants characterized by enhanced growth and methods and nucleic acid constructs useful for generating same
10/21/2009EP1392359B1 Specific binding proteins and uses thereof
10/21/2009EP1380649B1 Transformant producing pf1022 substance derivatives, process for producing the same and novel biosynthesis gene
10/21/2009EP1371373B1 Recombination super compound interferon used as hepatitis b surface antigen and e antigen inhibitor
10/21/2009EP1358345B1 Multitemperature single strand conformation polymorphism (msscp)
10/21/2009EP1320630B1 Degenerate oligonucleotide gene shuffling
10/21/2009EP1292680B1 Agonist anti-trk-c monoclonal antibodies
10/21/2009EP1169462B1 Oil comprising brassicastanol
10/21/2009EP1147217B1 A method of dna sequencing
10/21/2009EP1117672B1 Antisense modulation of survivin expression
10/21/2009EP1109576B1 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide
10/21/2009EP1047784B1 Neissera meningitidis antigens
10/21/2009EP1025241B2 Multiply-substituted protease variants
10/21/2009EP1007743B1 Enzymes mixture
10/21/2009EP0986372B1 Vesicular complexes and methods of making and using the same
10/21/2009EP0959899B9 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
10/21/2009CN101563463A Intergenic sites between conserved genes in the genome of modified vaccinia ankara (MVA) vaccinia virus
10/21/2009CN101563462A Methods for hybrid corn seed production and compositions produced therefrom